Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
Status:
Completed
Trial end date:
2017-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of meropenem to colistin is
better than colistin alone in the treatment of clinically significant infections caused by
multi-drug resistant bacteria